Skip to content

Our Devices

Introducing TAP® Micro and TAP® Micro Select

Our devices produce high-quality, whole blood samples at consistently high volumes of up to 900µL through virtually painless capillary blood collection, making them ideal for decentralized clinical trials, wellness testing, and clinical-grade blood sampling. Remote blood collection allows the opportunity to replace traditional phlebotomist-conducted venous blood collection or painful fingerstick tests in at home blood collection applications.

  • Discover how the proprietary HALO™ Technology enables virtually painless blood draws Learn More

TAP® Micro Select

TAP® Micro Select uses the same bladeless blood draw technology as TAP® Micro and takes the pain out of blood collection in decentralized clinical trials as well as health and wellness testing. Using HALO™ technology, a bladeless microneedle array, TAP® Micro Select enables virtually painless, large-volume collection of up to 900µL of whole, capillary high-quality blood.

  • FDA 510(k) Cleared
  • CE Marked
  • HALO™ Technology, bladeless microneedle array
  • Discover TAP® Micro Select’s expanded regulatory approval with award of CE Mark Read Article
Adhesive Liner
Tube Port

TAP® Micro

TAP® Micro offers an easy-to-remove detachable sample tube, with capillary blood collection volumes of as much as 900µL, and multiple sample tube type choices to meet customer needs. TAP® Micro devices have been successfully employed by hospitals and medical professionals for investigational use to conduct remote blood collection on a wide range of patients spanning ages and conditions, validating its flexibility and effectiveness in the field.

  • CE Marked
  • Investigational Use Only in the US
  • Pre-attached collection tubes
  • HALO™ Technology bladeless microneedle array
  • See how Columbia University is utilizing TAP® Technology to improve patient experiences at their fertility clinic Read Article
Adhesive Liner
Tube Cap
Product Guides
Learn more about TAP® Micro and TAP® Micro Select Explore Product Guides
Product Videos
See how our TAP® devices leverage the HALO™ Technology Explore Product Videos

Our Results Speak for Themselves

Up to 900µL of Whole Capillary Blood

Our HALO™ Technology enables patients to collect up to 900µL of blood, accommodating a broad range of standard blood tests1

Up to 99% Collection Success Rate

Our devices are end-user preferred, virtually painless, and yield up to a 99% collection success rate2

200% Increase in Patient Retention/Completion Rates in Clinical Trials

Significantly higher completion rates in clinical trials when compared to fingerstick3

98% of Patients Would Repeat Self-Collection

When asked if they would repeat their self-collection experience with TAP® Micro, 98% of patient respondents responded “yes”4

High Venous Concordance

For broad-based tests, such as cholesterol, capillary blood samples collected in both an assisted and self-collection setting have high concordance with venous blood5

Drawing Blood Doesn’t Have to Be a Pain in the Arm

We offer customizable sample management services, including kitting, fulfillment, and sample tracking from the end user to any central lab.

  • Interested in learning more about our TAP® devices and service offerings? Get in touch with our experts. Contact Us

Latest Research and Highlights

Discover the latest studies and reports published on our devices and solutions

View All
  • TAP® + Illumina NGS Platform enables High Quality Whole Exome Sequencing

    Use of TAP Point of Care Blood Collection Device for High-Quality Germline Whole Exome Sequencing on Illumina NGS Platforms with the Twist Bioscience Human Core WES Kit

    Read More
  • Enable remote access multiomics with just one TAP®

    Use of TAP Point of Care Blood Collection Device for Targeted Proteomics with the Olink Target 96 Cardiovascular II Panel Using Proximity Extension Assay Technology.

    Read More
  • TAP® technology shows promise for early, precise Alzheimer’s monitoring via biomarkers

    Use of the TAP Point of Care Blood Collection Device for Biomarker Assessments on the Quanterix Simoa HD-X Platform: Initial Feasibility for Plasma Biomarkers in Alzheimer’s Disease Detection.

    Read More
View All
  1. Citation: Citation: Internal data.
  2. Citation: Citation: This is a customer-reported statistic.
  3. Citation: Citation: This is a customer-reported statistic.
  4. Citation: Internal data.
  5. Citation: Collier, B. B., Brandon, W. C., Chappell, M. R., Kovach, P. M. & Grant, R. P. Maximizing Microsampling: Measurement of Comprehensive Metabolic and Lipid Panels Using a Novel Capillary Blood Collection Device. J. Appl. Lab. Med. jfad066 (2023) doi:10.1093/jalm/jfad066.